Skip to main content

Want a detailed portfolio tracker?

MetaVia (MTVA) P/E (2023 - 2026)

MetaVia (MTVA) P/E from Jun 30, 2023 to Jun 3, 2026. The TTM MetaVia (MTVA) P/E is -0.54. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MetaVia (MTVA)

YearP/EChange
2026-0.54-70.21%
2025-1.83-58.59%
2024-4.41-85.86%
2023-31.19N/A

Comparison MetaVia (MTVA) P/E with competitors

MetaVia (MTVA) P/E is -0.54.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.31%
NBYStablecoin Development Corp0.10-118.79%
ENLVEnlivex Therapeutics Ltd0.15-127.61%
FGENFibroGen Inc0.24-144.12%
TRAWTraws Pharma Inc0.47-186.90%
FBIOFortress Biotech Inc0.71-229.76%
CHRSCoherus Biosciences Inc0.98-279.77%
ORMPOramed Pharmaceuticals Inc1.47-370.80%
AGENAgenus Inc2.05-476.48%
VIVSVivoSim Labs Inc2.54-566.04%
INVAInnoviva Inc3.19-686.00%
CRMDCorMedix Inc3.65-770.03%
ABEOAbeona Therapeutics Inc4.20-872.83%
VXRTVaxart Inc4.26-883.23%
CVACCureVac N.V.4.45-917.05%
SRPTSarepta Therapeutics Inc4.62-949.87%
GLPGGalapagos NV4.86-992.99%
RIGLRigel Pharmaceuticals4.92-1004.15%
ZVRAZevra Therapeutics Inc4.97-1014.16%
ABUSArbutus Biopharma Corp5.69-1146.44%
CGENCompugen Ltd7.38-1457.09%
AUPHAurinia Pharmaceuticals Inc9.25-1800.32%
ACADAcadia Pharmaceuticals Inc9.59-1862.18%
OMEROmeros Corporation9.88-1916.47%
PLXProtalix BioTherapeutics Inc9.91-1921.20%
SPROSpero Therapeutics Inc10.73-2072.94%
ADMAAdma Biologics Inc11.33-2182.46%
SVASinovac Biotech Ltd11.44-2201.83%
TBPHTheravance Biopharma Inc11.78-2264.43%
HRMYHarmony Biosciences Holdings Inc12.18-2338.64%
TGTXTG Therapeutics Inc13.18-2522.25%
INCYIncyte Corp13.38-2559.49%
SABSSAB Biotherapeutics Inc14.06-2683.68%
XOMAXOMA Corp14.95-2846.79%
REGNRegeneron Pharmaceuticals Inc14.98-2853.23%
PBYIPuma Biotechnology Inc15.05-2866.13%
EXELExelixis Inc15.79-3002.94%
NAGENiagen Bioscience Inc16.35-3105.89%
CPRXCatalyst Pharmaceuticals Inc17.34-3287.80%
MDXGMimedx Group Inc17.38-3293.43%
ARGXArgen X SE23.07-4340.34%
HALOHalozyme Therapeutics Inc23.20-4364.05%
XOMAOXOMA Corp25.34-4758.14%
VRTXVertex Pharmaceuticals Inc25.66-4815.30%
XOMAPXOMA Corp25.67-4817.93%
CTMXCytomX Therapeutics Inc25.70-4823.04%
ASNDAscendis Pharma A/S26.35-4943.64%
RPRXRoyalty Pharma plc - Class A27.50-5153.40%
SLNOSoleno Therapeutics Inc29.02-5432.75%
LGNDLigand Pharmaceuticals Inc - Class B30.19-5648.01%
BMRNBiomarin Pharmaceutical Inc37.51-6993.50%
APLSApellis Pharmaceuticals Inc39.02-7271.74%
KRYSKrystal Biotech Inc39.70-7396.06%
GMABGenmab40.20-7489.05%
ONCBeiGene Ltd67.03-12418.95%
TECHBio-Techne Corp68.59-12707.16%
VCELVericel Corp80.63-14918.93%
PHARPharming Group N.V.87.74-16225.86%
ALNYAlnylam Pharmaceuticals Inc124.93-23061.70%
TLXTelix Pharmaceuticals Ltd139.89-25810.66%
CORTCorcept Therapeutics Inc158.39-29210.54%